Latest VirtualScopics Inc. Stories
Ms. Henderson Relocating to Europe ROCHESTER, N.Y., June 14, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that on June 12, 2013 Molly Henderson, its Chief Business and Financial Officer, Sr. Vice President notified the company of her intention to resign from the company effective August 31(st), 2013 due to the relocation of her family to Europe. Ms. Henderson will continue in her current role until August 31,...
Awards and Bookings Advance 40% over Year to Date 2012 ROCHESTER, N.Y., May 15, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced revenues of $2,532,587 for the quarter ended March 31, 2013 compared to $3,702,159 for the quarter ended March 31, 2012. Net loss for the three months ended March 31, 2013 was $1,112,948 compared to a net loss of $613,544 for the three months ended March 31, 2012. Other first quarter...
ROCHESTER, N.Y., April 30, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Wednesday, May 15, 2013 it will release its first quarter 2013 financial results. VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will host a conference call that morning at 11:00 a.m. ET to provide a business update and...
ROCHESTER, N.Y., Feb. 28, 2013 /PRNewswire/ -- VirtualScopics, Inc. (Nasdaq: VSCP) today announced that The Nasdaq Stock Market has informed the Company that it has been granted an additional 180 day period, or until August 26, 2013, to regain compliance with the minimum $1 bid price per share requirement. The determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial...
ROCHESTER, N.Y., Feb. 19, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced revenues of $12,963,164 for the year ended December 31, 2012 compared to $14,281,603 for the year ended December 31, 2011. Net loss for the twelve months ended December 31, 2012 was $1,528,652 compared to a net income of $703,295 for the twelve months ended December 31, 2011. Other full-year 2012 results include: Approximately $550,000 in...
ROCHESTER, N.Y., Jan. 30, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Tuesday, February 19, 2013 it will release its fourth quarter and full year 2012 financial results. VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will host a conference call that morning at 11:00 a.m. ET to provide a business update...
ROCHESTER, N.Y., Nov. 9, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative medical imaging, today reported revenues of $3,328,217 for the third quarter of 2012 compared to revenues of $3,268,807 in the third quarter of 2011. Gross profit for the quarter ended September 30, 2012 was $1,462,056 compared to $1,496,626 for the quarter ended September 30, 2011. Operating loss for the third quarter of 2012 was $53,293 compared to operating income...
ROCHESTER, N.Y., Oct. 24, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Friday, November 9, 2012 it will release its third quarter 2012 financial results. VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will host a conference call that morning at 11:00 a.m. ET to provide a business update and discuss the...
ROCHESTER, N.Y., Oct. 4, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging solutions, today announced that 2012 revenues are expected to be below the company's previous outlook as a result of delays in new study initiations and analysis services, as well as a slow-down in decisions on pending outstanding proposals. The company now expects 2012 revenues to be between $12.5 million and $13 million, compared to the previous expectation...
ROCHESTER, N.Y., Sept. 18, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging solutions, announced today that its patent titled Automated Measurement of Anatomical Structures in Medical Imaging recently received issuance in Canada. This is the 18(th) patent awarded to VirtualScopics worldwide for its algorithms and processes supporting quantitative medical imaging analysis. The company holds 10 patents within the United States....
